Tag: bid
AIG’s Nan Shan Life Insurance Unit Attracts Multiple Buyout Bids
by Dawn Kawamoto on Jan.05, 2011, under Towing
AIG, which wants to spin off its Taiwan-based Nan Shan Life Insurance unit, has a few live ones nibbling on the line to snap it up, according to a Bloomberg report. The company has disclosed in an SEC filing that Nan Shan has attracted unsolicited offers ranging from $2.15 billion to $3 billion.
Continue reading AIG’s Nan Shan Life Insurance Unit Attracts Multiple Buyout Bids
AIG’s Nan Shan Life Insurance Unit Attracts Multiple Buyout Bids originally appeared on DailyFinance on Wed, 05 Jan 2011 11:00:00.
Filed Under: Company News, American International Group, Insurance, Biz Brief
Seneca Blasts Icahn’s Bid for Power-Plant Operator Dynegy
by Melly Alazraki on Dec.20, 2010, under Towing
Last week, power-plant operator Dynegy agreed to be acquired by top shareholder Icahn Enterprises for about $665 million. But Dynegy’s second-largest shareholder, hedge fund Seneca Capital, rejected the bid, calling it “the wrong price at the wrong time for the wrong reasons.”
Continue reading Seneca Blasts Icahn’s Bid for Power-Plant Operator Dynegy
Seneca Blasts Icahn’s Bid for Power-Plant Operator Dynegy originally appeared on DailyFinance on Mon, 20 Dec 2010 15:40:00.
Filed Under: Energy, Company News, People, Stocks in the News
Genzyme Tries to Convince Sanofi-Aventis Its MS Drug Is Worth More
by Melly Alazraki on Dec.20, 2010, under Towing
The U.S. biotech is holding an analyst and investor meeting focused on the commercial potential of its multiple sclerosis drug Campath. The goal: to convince Paris-based Sanofi-Aventis to raise its hostile takeover offer in a battle that has now gone on for five months.
Continue reading Genzyme Tries to Convince Sanofi-Aventis Its MS Drug Is Worth More
Genzyme Tries to Convince Sanofi-Aventis Its MS Drug Is Worth More originally appeared on DailyFinance on Mon, 20 Dec 2010 10:50:00.
Filed Under: Company News, Genzyme Corporation , Sanofi Aventis, Stocks in the News





